Jade Biosciences Cash Flow Statement (2020-2026) | JBIO

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-53.21M-48.64M-8.27M-10.91M-43.85M-48.30M-15.78M-60.25M-50.25M-39.12M-22.18M-118.08M-26.88M-15.57M-46.98M-38.17M-70.00M-56.71M-34.98M-40.45M
Depreciation and Depletion (Quarter)
0.00M0.00M0.01M0.01M0.02M0.02M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.22M0.01M0.00M0.00M0.01M0.01M0.01M
Share-based Compensation (Quarter)
0.32M0.84M0.85M1.02M1.22M1.50M4.71M2.38M3.03M3.24M3.25M4.20M3.87M0.03M1.26M2.42M3.90M4.29M9.40M7.41M
Cash from Operations (Quarter)
-4.00M-6.53M-13.09M-5.66M-8.88M-9.72M-14.87M-11.42M-14.94M-15.61M-14.80M-23.67M-6.80M-22.61M-18.76M-20.16M-22.12M-33.66M-24.10M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.03M-0.06M-0.29M-0.59M-0.67M-0.64M-0.81M-0.94M-0.76M-0.69M-0.46M-0.34M-0.23M0.61M0.49M
Depreciation & Amortization (CF) (Quarter)
0.00M0.00M0.01M0.01M0.02M0.02M0.02M0.02M0.02M0.03M0.03M0.03M0.03M0.22M0.01M0.00M0.00M0.01M0.01M0.01M
Change in Working Capital
Change in Account Payables (Quarter)
-0.20M1.09M-1.04M1.59M-0.71M2.24M-1.75M2.12M0.77M-2.01M-1.04M0.83M0.95M0.30M1.29M2.68M2.26M-4.88M0.30M2.33M
Change in Accured Expenses (Quarter)
0.92M-0.03M0.03M0.50M-0.31M1.44M-1.77M0.72M1.84M-2.67M10.11M-3.06M0.59M0.24M3.98M-1.95M4.81M4.58M-3.50M5.77M
Other Working Capital Changes (Quarter)
-0.80M2.06M4.73M-2.13M-3.36M1.12M-0.30M-0.64M0.73M0.03M-0.61M2.11M2.65M0.21M0.27M0.51M0.85M0.41M10.20M-5.44M
Investing Activities
Capital Expenditures (Quarter)
-0.01M-0.01M0.03M0.40M-0.24M1.68M0.03M0.02M0.03M0.03M-0.00M-2.51M1.72M0.23M-0.06M-0.03M0.28M-0.15M
Change in Acquisitions & Divestments (Quarter)
12.52M47.23M30.25M64.75M31.00M36.75M34.75M33.50M23.58M18.00M21.00M13.13M12.85M65.43M
Cash from Investing Activities (Quarter)
-0.06M-113.34M-20.40M8.19M4.64M14.49M15.38M3.98M-13.13M5.65M8.83M13.13M12.85M-12.99M-148.71M-98.16M-8.47M
Financing Activities
Other financing activities (Quarter)
0.17M-0.02M0.22M0.33M-0.33M0.13M0.70M-0.40M-190.16M0.04M
Cash from Financing Activities (Quarter)
54.51M128.31M-0.25M0.04M0.36M0.22M45.29M0.02M0.46M0.47M94.77M92.00M-0.70M191.31M170.16M-0.80M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
55.53M63.68M-0.25M0.31M
Additional items
Exchange Rate Effect (Quarter)
-0.02M-0.01M
Change in Cash (Quarter)
50.51M121.73M-126.68M-26.06M-0.68M-5.04M-0.02M4.17M34.33M-28.72M-8.69M-14.37M87.97M69.39M-19.46M171.01M-170.84M38.33M-33.35M
Free Cash Flow (Quarter)
-4.00M-6.52M-13.08M-5.69M-9.28M-9.48M-16.55M-11.45M-14.96M-15.64M-14.83M-23.67M2.51M-8.52M-22.84M-18.70M-20.13M-22.41M-33.51M-24.10M
Net Cash Flow (Quarter)
50.51M121.73M-126.68M-26.06M-0.68M-5.04M-0.02M4.17M34.33M-28.72M-8.69M-14.37M87.97M82.52M-6.61M158.16M-170.83M38.34M-33.37M